FDA

FDA’s Review on Eteplirsen could Determine Quality of Life of Thousands

FDA’s Review on Eteplirsen could Determine Quality of Life of ThousandsFood and Drug Administration controls the fate of so many people and the government agency can also deny children a treatment which might help them to walk.

FDA Gives Green Signal to a New Breakthrough Drug for Lowering Cholesterol in High-Risk Patients

FDA Gives Green Signal to a New Breakthrough Drug for Lowering Cholesterol in High-Risk PatientsIn the past many drugs have been prescribed for lowering bad cholesterol. But a drug from Sanofi and Regeneron Pharmaceuticals Inc. offers better results for high risk patients.

On Friday, a first of its kind drug was approved by the Food and Drug Administration which lowers cholesterol that clogs the artery better than the drugs prescribed so far.

FDA Steps in to Seek Clarity on Terminology used on Sunscreen Labels

FDA Steps in to Seek Clarity on Terminology used on Sunscreen LabelsIn a rather alarming study, published online in the journal JAMA Dermatology, on June 17, researchers from the Northwestern University found that majority of Americans knew very little of the sunscreen that they wore each day.

Nutritional literacy can be enhanced by weekly text messages

Nutritional literacy can be enhanced by weekly text messagesContent informing could be utilized as a method for imparting the essentials of day by day consuming necessities that, notwithstanding open administration exertions, regularly go ignored, but are at the foundation of settling on sustenance decisions, a study via specialists at the Johns Hopkins Bloomberg School of Public Health found.

Majority of FDA Experts Vote against Selling Allergy Drug Singulair Over-the-Counter

Majority of FDA Experts Vote against Selling Allergy Drug Singulair Over-the-CounterMajority of panel of expert advisors to the US Food and Drug Administration voted against the proposal to move the allergy drug Singulair from prescription to over-the-counter status on Friday. Eleven experts voted against the move to allow selling of the popular medication without a doctor's approval compared to four in favor, reported the Associated Press.

US FDA Disapproval for a Painkiller pushes QRxPharma Share by 78%

US FDA Disapproval for a Painkiller pushes QRxPharma Share by 78%After losing the approval of US regulatory panel for a painkiller that combines two opioids, QRxPharma Ltd. stock lost the most in Sydney trading since its initial share sale in 2007.

Pages

Popular Stories